These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 4347503
1. The cancer associated antigen test as an index to failure of complete removal of urological cancers. Wechsler M, Lo Gerfo P, Feminella J, Lattimer JK. Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503 [No Abstract] [Full Text] [Related]
2. The cancer associated antigen test as an index to failure of complete removal of urological cancers. Wechsler M, Gerfo PL, Feminella J, Lattimer JK. J Urol; 1973 Apr; 109(4):699-701. PubMed ID: 4735168 [No Abstract] [Full Text] [Related]
3. Cutaneous response to dinitrochlorobenzene in patients with genito-urinary cancers. Duclos H, Schwarzenberg L, Duclos SH, Hugues H, Kuss R. Biomedicine; 1977 Jan 31; 27(1):43-7. PubMed ID: 856314 [Abstract] [Full Text] [Related]
4. Carcinoembryonic antigen and urothelial carcinoma. Hall RR, Laurence DJ, Neville AM, Wallace DM. Br J Urol; 1973 Feb 31; 45(1):88-92. PubMed ID: 4690154 [No Abstract] [Full Text] [Related]
5. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract]. Rost A, Kneppenberg U, Rost P. Helv Chir Acta; 1976 Jul 31; 43(3):271-8. PubMed ID: 947865 [Abstract] [Full Text] [Related]
6. Preliminary report of an immunological study in urological cancer. Serrallach N, Jimenez JF, Aguiló F, Anguera A, Clavo M, Orejas V, Torner V, Serrate R. Eur Urol; 1975 Jul 31; 1(2):99-100. PubMed ID: 1241896 [Abstract] [Full Text] [Related]
7. Autologous neoplastic isto-cryoprecipitates as immuno-stimulating treatment in 100 urological cancer patients. Marten-Perolino R, Cocimano V, Botto A, Buffa G, Riggi E, Trapani C. J Exp Pathol; 1987 Jul 31; 3(4):587-92. PubMed ID: 3454806 [No Abstract] [Full Text] [Related]
8. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer]. Tozuka K, Yonese Y, Nakagami Y, Minowa T, Hiraoka Y, Yamada N, Hikima N, Ishii Y, Tannowa K, Fujioka Y. Gan To Kagaku Ryoho; 1984 May 31; 11(5):1078-83. PubMed ID: 6721513 [Abstract] [Full Text] [Related]
9. Carcinoembryonic antigen in patients with tumors of the urogenital tract. Reynoso G, Chu TM, Guinan P, Murphy GP. Cancer; 1972 Jul 31; 30(1):1-4. PubMed ID: 5064805 [No Abstract] [Full Text] [Related]
10. Immunologic features of genitourinary cancer. Javadpour N. Urology; 1973 Aug 31; 2(2):103-8. PubMed ID: 4129366 [No Abstract] [Full Text] [Related]
11. Immunological evaluation in patients with urological cancers. Martinez-Piñeiro JA, Muntanola P, Hidalgo L. Eur Urol; 1977 Aug 31; 3(3):159-62. PubMed ID: 560302 [Abstract] [Full Text] [Related]
17. Plenary lecture: lymphocytic infiltration in relationship to urologic tumors. Mostofi FK, Sesterhenn I. Natl Cancer Inst Monogr; 1978 Dec 26; (49):133-41. PubMed ID: 571042 [Abstract] [Full Text] [Related]
18. [On the malignant tumors of the urogenital system]. Greissinger HH. Landarzt; 1966 May 31; 42(15):639-53. PubMed ID: 4293454 [No Abstract] [Full Text] [Related]
19. Treatment of tumors of genitourinary tract. Murphy GP. N Y State J Med; 1976 Feb 31; 76(2):214-22. PubMed ID: 55989 [No Abstract] [Full Text] [Related]